Cosmos Health Inc.
About Cosmos Health Inc.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $65.3M
- Net income
- -$19.1M
- Total assets
- $65.5M
- Market cap
- $15.0M
- Gross margin
- 12.1%
- Operating margin
- -25.6%
- Net margin
- -29.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $65.3M
- Cost of revenue
- $57.4M
- Gross profit
- $7.9M
- Operating expenses
- $24.6M
- Operating income
- -$16.7M
- Income tax
- $0
- Net income
- -$19.1M
- EPS (basic)
- $-0.63
- EPS (diluted)
- $-0.63
Balance sheet
- Total assets
- $65.5M
- Current assets
- $38.4M
- Total liabilities
- $47.1M
- Current liabilities
- $38.3M
- Shareholders’ equity
- $18.4M
Cash flow
- Operating cash flow
- -$8.4M
- Investing cash flow
- -$2.0M
- Financing cash flow
- $14.1M
- Net cash flow
- $8.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $15.0M
- EPS (diluted)
- $-0.63
- Shares outstanding
- 65.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 19, 2010
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $19.1M in FY2025.
- Revenue grew 30% from FY2022 to FY2025.
- Gross margin of 12.1%, net margin -29.3%.
- Trading 82% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cosmos Health Inc..
Write a review
News about Cosmos Health Inc.
News & sentiment via Polygon.io
